These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 38359944

  • 1. Long-Term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis in Japan: 10-Year Analysis of the Real-World TRUST Study.
    Takeuchi T, Wakasugi N, Hashida T, Uno S, Makino H.
    J Rheumatol; 2024 Jun 01; 51(6):613-621. PubMed ID: 38359944
    [Abstract] [Full Text] [Related]

  • 2. Long-term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis: 5-year Interim Postmarketing Surveillance Study in Japan (TRUST).
    Takeuchi T, Wakasugi N, Uno S, Makino H.
    J Rheumatol; 2021 Jan 01; 48(1):74-81. PubMed ID: 32238515
    [Abstract] [Full Text] [Related]

  • 3. Safety and Effectiveness of Once-Daily, Prolonged-Release Tacrolimus in De Novo Kidney Transplant Recipients: 5-year, Multicenter Postmarketing Surveillance in Japan.
    Wakasugi N, Uchida H, Uno S.
    Transplant Proc; 2018 Dec 01; 50(10):3296-3305. PubMed ID: 30577199
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tacrolimus use and renal function in pregnancy with lupus nephritis: Analysis of post-marketing surveillance data in Japan.
    Suzuki K, Uno S, Wakasugi N.
    Mod Rheumatol; 2023 Aug 25; 33(5):944-952. PubMed ID: 35982545
    [Abstract] [Full Text] [Related]

  • 6. Post-marketing surveillance study of the long-term use of mizoribine for the treatment of lupus nephritis: 2-Year results.
    Takeuchi T, Okada K, Yoshida H, Yagi N.
    Mod Rheumatol; 2018 Jan 25; 28(1):85-94. PubMed ID: 28722500
    [Abstract] [Full Text] [Related]

  • 7. Effect of Tacrolimus vs Intravenous Cyclophosphamide on Complete or Partial Response in Patients With Lupus Nephritis: A Randomized Clinical Trial.
    Zheng Z, Zhang H, Peng X, Zhang C, Xing C, Xu G, Fu P, Ni Z, Chen J, Xu Z, Zhao MH, Li S, Huang X, Miao L, Chen X, Liu B, He Y, Li J, Liu L, Kadeerbai H, Liu Z, Liu Z.
    JAMA Netw Open; 2022 Mar 01; 5(3):e224492. PubMed ID: 35353167
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of tacrolimus for maintenance therapy of lupus nephritis: a 5-year retrospective study at a single center.
    Karasawa K, Uchida K, Kodama M, Moriyama T, Nitta K.
    Rheumatol Int; 2018 Dec 01; 38(12):2271-2277. PubMed ID: 30203113
    [Abstract] [Full Text] [Related]

  • 9. Immunosuppressive treatment for proliferative lupus nephritis.
    Tunnicliffe DJ, Palmer SC, Henderson L, Masson P, Craig JC, Tong A, Singh-Grewal D, Flanc RS, Roberts MA, Webster AC, Strippoli GF.
    Cochrane Database Syst Rev; 2018 Jun 29; 6(6):CD002922. PubMed ID: 29957821
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases.
    Cortés-Hernández J, Torres-Salido MT, Medrano AS, Tarrés MV, Ordi-Ros J.
    Nephrol Dial Transplant; 2010 Dec 29; 25(12):3939-48. PubMed ID: 20538787
    [Abstract] [Full Text] [Related]

  • 11. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice.
    Tanaka H, Watanabe S, Aizawa-Yashiro T, Oki E, Kumagai N, Tsuruga K, Ito E.
    Nephron Clin Pract; 2012 Dec 29; 121(3-4):c165-73. PubMed ID: 23327881
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of tacrolimus therapy for lupus nephritis: a systematic review of clinical trials.
    Lee YH, Lee HS, Choi SJ, Dai Ji J, Song GG.
    Lupus; 2011 May 29; 20(6):636-40. PubMed ID: 21382917
    [Abstract] [Full Text] [Related]

  • 13. Long-term data on tacrolimus treatment in lupus nephritis.
    Yap DY, Ma MK, Mok MM, Kwan LP, Chan GC, Chan TM.
    Rheumatology (Oxford); 2014 Dec 29; 53(12):2232-7. PubMed ID: 24996908
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
    Sakai R, Kurasawa T, Nishi E, Kondo T, Okada Y, Shibata A, Nishimura K, Chino K, Okuyama A, Takei H, Nagasawa H, Amano K.
    Lupus; 2018 Feb 29; 27(2):273-282. PubMed ID: 28683654
    [Abstract] [Full Text] [Related]

  • 17. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.
    Liu Z, Zhang H, Liu Z, Xing C, Fu P, Ni Z, Chen J, Lin H, Liu F, He Y, He Y, Miao L, Chen N, Li Y, Gu Y, Shi W, Hu W, Liu Z, Bao H, Zeng C, Zhou M.
    Ann Intern Med; 2015 Jan 06; 162(1):18-26. PubMed ID: 25383558
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.